Whole Genome Sequencing: Global Markets

Report Scope

This report highlights the current and future market potential of whole genome sequencing (WGS) and provides in-depth market estimates. This data-focused report covers market projections until 2030 at the global and regional levels for each segment. It provides market estimates and forecasts based on the product and service type, sequencing type, workflow end user, application and region. By product and service, the market is segmented into instruments, consumables and services.

By workflow, the segments include pre-sequencing, sequencing and data analysis. Based on the end user, the market is segmented into research institutes, hospitals and clinics, pharmaceutical companies, and others. By application, the market is categorized as infectious diseases, cancer research, rare genetic diseases, pharmacogenomics and others. Geographical regions include North America, Europe, Asia-Pacific and the Rest of the World (RoW). The report includes global revenue ($ millions) for the base year 2024, estimated data for 2025, and forecasts of CAGRs through 2030.

Report Includes

• 67 data tables
• Industry insights and a brief overview of the global market for whole genome sequencing (WGS) technology
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, including projections of CAGRs through 2030
• Evaluation of the current market size and revenue growth prospects for the global market, accompanied by a market share analysis by product and service type, workflow, application, end user, and region
• Country specific sales data and analysis for the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, India, South Korea, Australia, Rest of Europe, Rest of Asia-Pacific, South America, the Middle East and Africa